Casper Sleep Inc (CSPR) Stock Fundamental Analysis

NYSE:CSPR

6.78
+0.48 (+7.62%)
At close: Jan 24, 2022
6.71
-0.07 (-1.03%)
Pre-Market: 1/25/2022, 7:28:35 AM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

1

CSPR gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 60 industry peers in the Household Durables industry. CSPR has a bad profitability rating. Also its financial health evaluation is rather negative. CSPR is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • CSPR had negative earnings in the past year.
CSPR Yearly Net Income VS EBIT VS OCF VS FCFCSPR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 -20M -40M -60M -80M

1.2 Ratios

Industry RankSector Rank
ROA -43.28%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CSPR Yearly ROA, ROE, ROICCSPR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 -200 -400 -600

1.3 Margins

Industry RankSector Rank
OM -11.31%
PM (TTM) -16.24%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CSPR Yearly Profit, Operating, Gross MarginsCSPR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 0 20 -20 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. Health

2.1 Basic Checks

  • CSPR has more shares outstanding than it did 1 year ago.
  • CSPR has a worse debt/assets ratio than last year.
CSPR Yearly Shares OutstandingCSPR Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 10M 20M 30M 40M
CSPR Yearly Total Debt VS Total AssetsCSPR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 50M 100M 150M 200M

2.2 Solvency

  • Based on the Altman-Z score of -1.27, we must say that CSPR is in the distress zone and has some risk of bankruptcy.
  • CSPR has a Debt/Equity ratio of -1.18. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity -1.18
Debt/FCF N/A
Altman-Z -1.27
ROIC/WACCN/A
WACCN/A
CSPR Yearly LT Debt VS Equity VS FCFCSPR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 0 50M -50M 100M

2.3 Liquidity

  • CSPR has a Current Ratio of 0.87. This is a bad value and indicates that CSPR is not financially healthy enough and could expect problems in meeting its short term obligations.
  • CSPR has a Quick Ratio of 0.87. This is a bad value and indicates that CSPR is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.87
Quick Ratio 0.46
CSPR Yearly Current Assets VS Current LiabilitesCSPR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 50M 100M 150M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. Growth

3.1 Past

  • CSPR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 59.42%, which is quite impressive.
  • Looking at the last year, CSPR shows a very strong growth in Revenue. The Revenue has grown by 23.79%.
  • The Revenue has been growing by 25.59% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)59.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-56.41%
Revenue 1Y (TTM)23.79%
Revenue growth 3Y25.59%
Revenue growth 5YN/A
Sales Q2Q%26.75%

3.2 Future

  • Based on estimates for the next years, CSPR will show a small growth in Earnings Per Share. The EPS will grow by 6.82% on average per year.
  • The Revenue is expected to grow by 16.02% on average over the next years. This is quite good.
EPS Next Y28.13%
EPS Next 2Y21.54%
EPS Next 3Y17.23%
EPS Next 5Y6.82%
Revenue Next Year24.47%
Revenue Next 2Y19.52%
Revenue Next 3Y17.78%
Revenue Next 5Y16.02%

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
CSPR Yearly Revenue VS EstimatesCSPR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
CSPR Yearly EPS VS EstimatesCSPR Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 -0.5 -1 -1.5 -2

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • CSPR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CSPR. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CSPR Price Earnings VS Forward Price EarningsCSPR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -6.22
CSPR Per share dataCSPR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

  • CSPR's earnings are expected to grow with 17.23% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y21.54%
EPS Next 3Y17.23%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • CSPR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

Casper Sleep Inc

NYSE:CSPR (1/24/2022, 8:33:37 PM)

Premarket: 6.71 -0.07 (-1.03%)

6.78

+0.48 (+7.62%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)N/A
Earnings (Next)02-28
Inst Owners0.04%
Inst Owner Change0%
Ins Owners13.73%
Ins Owner Change0%
Market Cap282.18M
Revenue(TTM)586.29M
Net Income(TTM)-95.22M
Analysts72.86
Price Target7.52 (10.91%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.48
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA -6.22
EPS(TTM)-1.83
EYN/A
EPS(NY)-1.24
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS14.09
BVpS-1.03
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -43.28%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -11.31%
PM (TTM) -16.24%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover2.66
Health
Industry RankSector Rank
Debt/Equity -1.18
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.87
Quick Ratio 0.46
Altman-Z -1.27
F-Score2
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)59.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-56.41%
EPS Next Y28.13%
EPS Next 2Y21.54%
EPS Next 3Y17.23%
EPS Next 5Y6.82%
Revenue 1Y (TTM)23.79%
Revenue growth 3Y25.59%
Revenue growth 5YN/A
Sales Q2Q%26.75%
Revenue Next Year24.47%
Revenue Next 2Y19.52%
Revenue Next 3Y17.78%
Revenue Next 5Y16.02%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

Casper Sleep Inc / CSPR FAQ

What is the fundamental rating for CSPR stock?

ChartMill assigns a fundamental rating of 2 / 10 to CSPR.


Can you provide the valuation status for Casper Sleep Inc?

ChartMill assigns a valuation rating of 0 / 10 to Casper Sleep Inc (CSPR). This can be considered as Overvalued.


Can you provide the profitability details for Casper Sleep Inc?

Casper Sleep Inc (CSPR) has a profitability rating of 0 / 10.


Can you provide the expected EPS growth for CSPR stock?

The Earnings per Share (EPS) of Casper Sleep Inc (CSPR) is expected to grow by 28.13% in the next year.